A monocentric, open-label randomized standard-of-care controlled study of XONRID®, a medical device for the prevention and treatment of radiation-induced dermatitis in breast and head and neck cancer patients.
Ingargiola R, De Santis MC, Iacovelli NA, Facchinetti N, Cavallo A, Ivaldi E, Dispinzieri M, Franceschini M, Giandini C, Romanello DA, Di Biaso S, Sabetti M, Locati L, Alfieri S, Bossi P, Guglielmo M, Macchi F, Lozza L, Valdagni R, Fallai C, Pignoli E, Orlandi E.
Ingargiola R, et al. Among authors: bossi p.
Radiat Oncol. 2020 Aug 13;15(1):193. doi: 10.1186/s13014-020-01633-0.
Radiat Oncol. 2020.
PMID: 32791985
Free PMC article.
Clinical Trial.